Acelyrin Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.25

Current Ratio	3.25
Quick Ratio	3.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	0.46%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	83
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.67% in the last 52 weeks. The beta is 1.09, so Acelyrin's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-47.67%
50-Day Moving Average	2.42
200-Day Moving Average	3.63
Relative Strength Index (RSI)	47.51
Average Volume (20 Days)	1,074,676

Short Selling Information

The latest short interest is 3.57 million, so 3.54% of the outstanding shares have been sold short.

Short Interest	3.57M
Short Previous Month	3.69M
Short % of Shares Out	3.54%
Short % of Float	5.21%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	250.00M
Gross Profit	250.00M
Operating Income	10.00M
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	10.00M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $10.00 million in cash and n/a in debt, giving a net cash position of $10.00 million.

Cash & Cash Equivalents	10.00M
Total Debt	n/a
Net Cash	10.00M
Net Cash Per Share	n/a
Equity (Book Value)	2.18B
Book Value Per Share	495.41
Working Capital	180.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-170.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	4.00%
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	4.00%
FCF Margin	n/a

Dividends & Yields

Acelyrin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for Acelyrin is $9.60, which is 326.67% higher than the current price. The consensus rating is "Hold".

Price Target	$9.60
Price Target Difference	326.67%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	29.71%
EPS Growth Forecast (5Y)	-29.07%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a